HHLR ADVISORS LTD
Q4 2021 Form 13-F

GRAND CAYMAN, CAYMAN ISLANDS
CIK 0001762304 · CRD 166112 · Exempt reporting adviser
Holdings reported by Evergreen Quality Fund GP Ltd since Q1 2024
Consolidated report · includes 1 manager since Q3 2019
$6.5B Reported Value Total

HHLR ADVISORS, LTD. reports 25 total accounts under management (AUM). There are 19 discretionary accounts valued at $63,691,555,481, and 6 non-discretionary accounts valued at $1,837,128,935.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Exempt Reporting Adviser Discretionary & Non-Discretionary
Private funds (Form ADV)
4 funds · $41.6B gross asset value
Hedge Fund: $41.6B
Source: Form ADV filed 2026-03-31
Reported value
$6.5B
Quarter over quarter
-18.7%
Holdings
76
Top-10 concentration
71.2%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Lei Zhang
SHAREHOLDER
Richard A. Hornung
CO-CHIEF OPERATING OFFICER, GENERAL COUNSEL
Bridget Nichola Kidner
DIRECTOR

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2021 13F record

Q4 2021 13F filing summary

Q4 2021 Form 13F portfolio summary
Period of report December 31, 2021
Filed February 14, 2022
Form 13F-HR
Reported value $6.5B
Positions 76
Change in reported value -15.4%
New positions 3
Exited positions 12
Position turnover 17.1%
Top-10 concentration 71.2%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
40 $1.5B
Q2 2026 13F
Filed Aug 14, 2026
35 $832.1M
Q1 2026 13F
Filed May 15, 2026
38 $1.7B
Q4 2025 13F
Filed Feb 17, 2026
33 $3.1B
Q3 2025 13F
Filed Nov 14, 2025
33 $4.1B
Q2 2025 13F
Filed Aug 14, 2025
36 $3.1B
Q1 2025 13F
Filed May 15, 2025
49 $3.5B
Q4 2024 13F
Filed Feb 14, 2025
45 $2.9B
Q3 2024 13F
Filed Nov 14, 2024
48 $4.6B
Q2 2024 13F
Filed Aug 14, 2024
78 $4.1B
Q1 2024 13F
Filed May 14, 2024
63 $4.6B
Q4 2023 13F
Filed Feb 14, 2024
49 $5.0B
Q3 2023 13F
Filed Nov 14, 2023
60 $4.5B
Q2 2023 13F
Filed Aug 14, 2023
60 $4.7B
Q1 2023 13F
Filed May 15, 2023
70 $5.6B
Q4 2022 13F
Filed Feb 14, 2023
67 $4.7B
Q3 2022 13F
Filed Nov 14, 2022
61 $3.8B
Q2 2022 13F
Filed Aug 15, 2022
64 $4.7B
Q1 2022 13F
Filed May 16, 2022
64 $4.8B
Q4 2021 13F
Filed Feb 14, 2022
76 $6.5B

12 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2021

Largest Q4 2021 13F positions by reported value
# Holding Reported value % of portfolio
1 ONC BEIGENE LTD $1.5B 22.91%
2 ONON ON HLDG AG $604.0M 9.33%
3 LEGN LEGEND BIOTECH CORP $550.2M 8.5%
4 CRM SALESFORCE COM INC $490.4M 7.58%
5 NBP I MAB $340.4M 5.26%
6 JD JD.COM INC $334.0M 5.16%
7 SE SEA LTD $276.9M 4.28%
8 DASH DOORDASH INC $193.0M 2.98%
9 IQ IQIYI INC $176.2M 2.72%
10 LI LI AUTO INC $160.7M 2.48%
11 CTKB CYTEK BIOSCIENCES INC $142.9M 2.21%
12 MDLZ MONDELEZ INTL INC $123.5M 1.91%
13 ENFN ENFUSION INC $104.2M 1.61%
14 BEKE KE HLDGS INC $100.8M 1.56%
15 BBIO BRIDGEBIO PHARMA INC $89.4M 1.38%
16 YSGXXXX YATSEN HLDG LTD $87.0M 1.34%
17 GOSS GOSSAMER BIO INC $83.9M 1.3%
18 VIPS VIPSHOP HOLDINGS LIMITED $75.3M 1.16%
19 ERAS ERASCA INC15.58 $73.6M 1.14%
20 CPNG COUPANG INC $71.3M 1.1%

Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings